trending Market Intelligence /marketintelligence/en/news-insights/trending/_4pboxDq6RcTvDNAd6JCag2 content esgSubNav
In This List

Imprimis Pharmaceuticals to raise $9.8M via private placement

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Imprimis Pharmaceuticals to raise $9.8M via private placement

Imprimis Pharmaceuticals Inc. plans to raise $9.8 million in a private placement of units.

The company will issue 5.1 million units at $1.915 apiece with each unit comprising 1 stock and a warrant to purchase another Imprimis share for $1.79 apiece within three years from issue.

The warrants are nonexercisable within the first six months of issue.

Funds raised will help Imprimis advance its eye business. The offering is expected to close Dec. 23 with National Securities Corp. acting as exclusive placement agent.